Important AI Milestone at Mass General Brigham in Boston -- 1) Mass General Brigham is using an AI model that has reduced the waiting period for breast imaging results from days to 15 minutes. This helps hospitals reduce time and effort needed to annotate new datasets.

Today, Motilent, the first company to specialise in the assessment of digestive diseases using AI medical image analysis, announces a total of  £1.2M National Institute for Health and Care Research (NIHR) funding to develop and roll out its  technology into more than 10 UK hospitals, including UCLH, Nottingham University Hospital and Frimley Park Hospital. Crohn’s Disease is a painful, debilitating inflammatory bowel condition that affects 115,000 people in the UK, with 33% diagnosed before age 21. Currently, anti-inflammatory medications are the standard of care. However, for the 40% who do not experience inflammatory symptoms, these medications are ineffective and can cause severe side effects, as well as costing the UK economy over £280 million every year. Currently, 69% of the UK population experiences persistent gut issues, […]

Drones are being used to carry Covid-19 test samples and other medical materials up to 40 miles (64km) across four locations in western Scotland. London drone firm Skyports has become the first operator to receive permission from the UK Civil Aviation Authority (CAA) to carry diagnostic specimens by drone. Cargo – including test samples, medicine, personal protective equipment (PPE) and Covid-19 testing kits – is being transported by the drones in the Argyll & Bute region. A whole fleet of the drones are carrying up to 3kg of the supplies each, improving services for patients and healthcare staff in one of the UK's most remote areas. Drones can complete a journey that takes a whopping 36 hours by road and ferry to just 15 minutes, while increasing the frequency of pick-ups.

Google-owned DeepMind is to collaborate with a UK hospital to help doctors spot more than 50 different eye diseases using AI. When it isn't creating artificial intelligence (AI) capable of destroying human opponents in a game of Go, Google-owned DeepMind is trying to build other systems that could transform healthcare, among other things. Now, the UK-based company has revealed a joint research partnership with Moorfields Eye Hospital that could help spot sight-threatening eye diseases much quicker than before. Publishing its findings in Nature Medicine, the company said that its latest AI can quickly run through eye scans taken from routine clinical practice and identify more than 50 serious diseases as accurately as world-leading expert doctors. Under existing systems, ophthalmologists use 3D images called optical coherence tomography (OCT) to create a detailed map of a person's eye.